{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:12:48Z","timestamp":1792725168869,"version":"4.5.0"},"reference-count":33,"publisher":"Tohoku University Medical Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2023]]},"DOI":"10.1620\/tjem.2023.j015","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T22:11:12Z","timestamp":1677708672000},"page":"35-45","source":"Crossref","is-referenced-by-count":10,"title":["Polysaccharide H-1-2 Ameliorates High Glucose-Induced Podocyte Dysfunction by Suppressing Epithelial-to-Mesenchymal Transition via Restoration of SIRT1 &lt;i&gt;in Vivo&lt;\/i&gt; and &lt;i&gt;in Vitro&lt;\/i&gt;"],"prefix":"10.1620","volume":"260","author":[{"given":"Minzhou","family":"Li","sequence":"first","affiliation":[{"name":"Department of Traditional Chinese Medicine, the People\u2019s Hospital of Inner Mongolia Autonomous Region"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, the People\u2019s Hospital of Inner Mongolia Autonomous Region"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, the People\u2019s Hospital of Inner Mongolia Autonomous Region"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiying","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, the People\u2019s Hospital of Inner Mongolia Autonomous Region"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, the People\u2019s Hospital of Inner Mongolia Autonomous Region"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyan","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Inner Mongolia Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Deng","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Inner Mongolia Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Niu","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Inner Mongolia Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Alicic, R.Z., Rooney, M.T. &amp; Tuttle, K.R. (2017)  Diabetic kidney disease: challenges, progress, and possibilities.  <i>Clin. J. Am. Soc. Nephrol.<\/i>, 12, 2032-2045.","DOI":"10.2215\/CJN.11491116"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Badid, C., Vincent, M., Fouque, D., Laville, M. &amp; Desmouliere, A. (2001)  Myofibroblast: a prognostic marker and target cell in progressive renal disease.  <i>Ren. Fail.<\/i>, 23, 543-549.","DOI":"10.1081\/JDI-100104736"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Barutta, F., Bellini, S. &amp; Gruden, G. (2022)  Mechanisms of podocyte injury and implications for diabetic nephropathy.  <i>Clin. Sci.<\/i> (<i>Lond.<\/i>), 136, 493-520.","DOI":"10.1042\/CS20210625"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Chuang, P.Y., Dai, Y., Liu, R., He, H., Kretzler, M., Jim, B., Cohen, C.D. &amp; He, J.C. (2011)  Alteration of forkhead box O (foxo4)  acetylation mediates apoptosis of podocytes in diabetes mellitus.  <i>PLoS One<\/i>, 6, e23566.","DOI":"10.1371\/journal.pone.0023566"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Dai, H., Liu, Q. &amp; Liu, B. (2017)  Research progress on mechanism of podocyte depletion in diabetic nephropathy.  <i>J. Diabetes Res.<\/i>, 2017, 2615286.","DOI":"10.1155\/2017\/2615286"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Dai, H.Y., Zheng, M., Tang, R.N., Ni, J., Ma, K.L., Li, Q. &amp; Liu, B.C. (2011)  Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.  <i>Am. J. Med. Sci.<\/i>, 341, 207-214.","DOI":"10.1097\/MAJ.0b013e3182010da9"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Du, L., Qian, X., Li, Y., Li, X.Z., He, L.L., Xu, L., Liu, Y.Q., Li, C.C., Ma, P., Shu, F.L., Lu, Q. &amp; Yin, X.X. (2021)  Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy.  <i>Acta Pharmacol. Sin.<\/i>, 42, 242-251.","DOI":"10.1038\/s41401-020-0450-2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Fang, Z.H., Duan, X.C., Zhao, J.D., Wu, Y.J. &amp; Liu, M.M. (2018)  Novel polysaccharide H-1-2 from pseudostellaria heterophylla alleviates type 2 diabetes mellitus.  <i>Cell. Physiol. Biochem.<\/i>, 49, 996-1006.","DOI":"10.1159\/000493284"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Gross, J.L., de Azevedo, M.J., Silveiro, S.P., Canani, L.H., Caramori, M.L. &amp; Zelmanovitz, T. (2005)  Diabetic nephropathy: diagnosis, prevention, and treatment.  <i>Diabetes Care<\/i>, 28, 164-176.","DOI":"10.2337\/diacare.28.1.164"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Hasegawa, K., Wakino, S., Simic, P., Sakamaki, Y., Minakuchi, H., Fujimura, K., Hosoya, K., Komatsu, M., Kaneko, Y., Kanda, T., Kubota, E., Tokuyama, H., Hayashi, K., Guarente, L. &amp; Itoh, H. (2013)  Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes.  <i>Nat. Med.<\/i>, 19, 1496-1504.","DOI":"10.1038\/nm.3363"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Kim, J.J., Li, J.J., Jung, D.S., Kwak, S.J., Ryu, D.R., Yoo, T.H., Han, S.H., Choi, H.Y., Kim, H.J., Han, D.S. &amp; Kang, S.W. (2007)  Differential expression of nephrin according to glomerular size in early diabetic kidney disease.  <i>J. Am. Soc. Nephrol.<\/i>, 18, 2303-2310.","DOI":"10.1681\/ASN.2006101145"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Kitada, M., Takeda, A., Nagai, T., Ito, H., Kanasaki, K. &amp; Koya, D. (2011)  Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa\/fa)  rats: a model of type 2 diabetes.  <i>Exp. Diabetes Res.<\/i>, 2011, 908185.","DOI":"10.1155\/2011\/908185"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Li, J.J., Kwak, S.J., Jung, D.S., Kim, J.J., Yoo, T.H., Ryu, D.R., Han, S.H., Choi, H.Y., Lee, J.E., Moon, S.J., Kim, D.K., Han, D.S. &amp; Kang, S.W. (2007)  Podocyte biology in diabetic nephropathy.  <i>Kidney Int. Suppl.<\/i>, S36-42.","DOI":"10.1038\/sj.ki.5002384"},{"key":"14","unstructured":"Li, M.Z., Wu, Z., Zhang, R.X., Gao, W. &amp; Zhao, K.Y. (2018)  Effects of Tai Ling pills on renal protection of the rats with STZ-induced diabetic nephropathy.  <i>Gansu Journal of Traditional Chinese Medicine<\/i>, 31, 5-9."},{"key":"15","doi-asserted-by":"crossref","unstructured":"Li, Y., Kang, Y.S., Dai, C., Kiss, L.P., Wen, X. &amp; Liu, Y. (2008)  Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria.  <i>Am. J. Pathol.<\/i>, 172, 299-308.","DOI":"10.2353\/ajpath.2008.070057"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Liu, J., Gao, L.D., Fu, B., Yang, H.T., Zhang, L., Che, S.Q., Xu, Y., Du, X., Liu, Z.C., Xue, Y., Lv, C.X., Huang, Y.H., Wang, B.H., Gao, S.X., Xing, Y.F., et al.  (2022)  Efficacy and safety of Zicuiyin decoction on diabetic kidney disease: a multicenter, randomized controlled trial.  <i>Phytomedicine<\/i>, 100, 154079.","DOI":"10.1016\/j.phymed.2022.154079"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Liu, X., Liu, L., Chen, P., Zhou, L., Zhang, Y., Wu, Y., Jiang, L., Cheng, D., Huang, W. &amp; Yi, D. (2014)  Clinical trials of traditional Chinese medicine in the treatment of diabetic nephropathy--a systematic review based on a subgroup analysis.  <i>J. Ethnopharmacol.<\/i>, 151, 810-819.","DOI":"10.1016\/j.jep.2013.11.028"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Livak, K.J. &amp; Schmittgen, T.D. (2001)  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))  Method.  <i>Methods<\/i>, 25, 402-408.","DOI":"10.1006\/meth.2001.1262"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Loeffler, I. &amp; Wolf, G. (2015)  Epithelial-to-mesenchymal transition in diabetic nephropathy: fact or fiction?  <i>Cells<\/i>, 4, 631-652.","DOI":"10.3390\/cells4040631"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Mou, X., Zhou, D.Y., Zhou, D., Liu, K., Chen, L.J. &amp; Liu, W.H. (2020)  A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.  <i>Phytomedicine<\/i>, 69, 153192.","DOI":"10.1016\/j.phymed.2020.153192"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Qi, Z., Fujita, H., Jin, J., Davis, L.S., Wang, Y., Fogo, A.B. &amp; Breyer, M.D. (2005)  Characterization of susceptibility of inbred mouse strains to diabetic nephropathy.  <i>Diabetes<\/i>, 54, 2628-2637.","DOI":"10.2337\/diabetes.54.9.2628"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Ruotsalainen, V., Ljungberg, P., Wartiovaara, J., Lenkkeri, U., Kestila, M., Jalanko, H., Holmberg, C. &amp; Tryggvason, K. (1999)  Nephrin is specifically located at the slit diaphragm of glomerular podocytes.  <i>Proc. Natl. Acad. Sci. U. S. A.<\/i>, 96, 7962-7967.","DOI":"10.1073\/pnas.96.14.7962"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Simic, P., Williams, E.O., Bell, E.L., Gong, J.J., Bonkowski, M. &amp; Guarente, L. (2013)  SIRT1 suppresses the epithelial-to-mesenchymal transition in cancer metastasis and organ fibrosis.  <i>Cell Rep.<\/i>, 3, 1175-1186.","DOI":"10.1016\/j.celrep.2013.03.019"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Simonson, M.S. (2007)  Phenotypic transitions and fibrosis in diabetic nephropathy.  <i>Kidney Int.<\/i>, 71, 846-854.","DOI":"10.1038\/sj.ki.5002180"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Sun, H., Shi, K., Qi, K., Kong, H., He, Q. &amp; Zhou, M. (2020)  Pseudostellaria heterophylla extract polysaccharide H-1-2 suppresses pancreatic cancer by inhibiting hypoxia-induced AG2.  <i>Mol. Ther. Oncolytics<\/i>, 17, 61-69.","DOI":"10.1016\/j.omto.2020.03.007"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Susztak, K., Raff, A.C., Schiffer, M. &amp; Bottinger, E.P. (2006)  Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.  <i>Diabetes<\/i>, 55, 225-233.","DOI":"10.2337\/diabetes.55.01.06.db05-0894"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Tu, Q., Li, Y., Jin, J., Jiang, X., Ren, Y. &amp; He, Q. (2019)  Curcumin alleviates diabetic nephropathy via inhibiting podocyte mesenchymal transdifferentiation and inducing autophagy in rats and MPC5 cells.  <i>Pharm. Biol.<\/i>, 57, 778-786.","DOI":"10.1080\/13880209.2019.1688843"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Wakino, S., Hasegawa, K. &amp; Itoh, H. (2015)  Sirtuin and metabolic kidney disease.  <i>Kidney Int.<\/i>, 88, 691-698.","DOI":"10.1038\/ki.2015.157"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Xu, Y., Nie, L., Yin, Y.G., Tang, J.L., Zhou, J.Y., Li, D.D. &amp; Zhou, S.W. (2012)  Resveratrol protects against hyperglycemia-induced oxidative damage to mitochondria by activating SIRT1 in rat mesangial cells.  <i>Toxicol. Appl. Pharmacol.<\/i>, 259, 395-401.","DOI":"10.1016\/j.taap.2011.09.028"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Yacoub, R., Lee, K. &amp; He, J.C. (2014)  The role of SIRT1 in diabetic kidney disease.  <i>Front. Endocrinol. <\/i>(<i>Lausanne<\/i>), 5, 166.","DOI":"10.3389\/fendo.2014.00166"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Yamaguchi, Y., Iwano, M., Suzuki, D., Nakatani, K., Kimura, K., Harada, K., Kubo, A., Akai, Y., Toyoda, M., Kanauchi, M., Neilson, E.G. &amp; Saito, Y. (2009)  Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy.  <i>Am. J. Kidney Dis.<\/i>, 54, 653-664.","DOI":"10.1053\/j.ajkd.2009.05.009"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Zhang, X.X., Kong, J. &amp; Yun, K. (2020)  Prevalence of diabetic nephropathy among patients with type 2 diabetes mellitus in China: a meta-analysis of observational studies.  <i>J. Diabetes Res.<\/i>, 2020, 2315607.","DOI":"10.1155\/2020\/2315607"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Zhong, Y., Lee, K. &amp; He, J.C. (2018)  SIRT1 is a potential drug target for treatment of diabetic kidney disease.  <i>Front. Endocrinol. <\/i>(<i>Lausanne<\/i>), 9, 624.","DOI":"10.3389\/fendo.2018.00624"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/260\/1\/260_2023.J015\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T04:06:43Z","timestamp":1683950803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/260\/1\/260_2023.J015\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2023.j015","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"2023.J015"}}